Literature DB >> 3151165

Derivation of urinary dopamine from plasma dopa.

R Zimlichman1, P D Levinson, G Kelly, R Stull, H R Keiser, D S Goldstein.   

Abstract

1. We estimated the extent to which circulating dopa (3,4-dihydroxyphenylalanine) is the source of urinary dopamine (DA; 3,4-dihydroxyphenethylamine). Tritiated dopa ([3H]dopa) was infused for 90 min into the left renal artery of seven anaesthetized foxhounds, and levels of labelled and unlabelled dopa and DA were measured in the ureteral urine and in the femoral arterial and left renal venous plasma. 2. Only a small percentage of [3H]dopa delivered to the kidneys was excreted as [3H]DA (0.59% from the left kidney, 0.68% from the right); however, the arterial concentration of endogenous dopa (1220 pg/ml) and the renal plasma flows (144 and 141 ml/min by p-aminohippurate clearances) were such that all of the urinary excretion of endogenous DA (about 1 ng/min from each kidney) could be accounted for by uptake and decarboxylation of circulating endogenous dopa. 3. Plasma dopa is the main source of urinary DA.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3151165     DOI: 10.1042/cs0750515

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  9 in total

Review 1.  Concepts of scientific integrative medicine applied to the physiology and pathophysiology of catecholamine systems.

Authors:  David S Goldstein
Journal:  Compr Physiol       Date:  2013-10       Impact factor: 9.090

2.  Studies on the pharmacology of the inward transport of L-DOPA in rat renal tubules.

Authors:  P C Pinto-do-O; P Soares-da-Silva
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

3.  Characterization of a dopamine receptor (DA2K) in the kidney inner medulla.

Authors:  T Huo; M Q Ye; D P Healy
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

4.  Impaired intrarenal dopamine production following intravenous sodium chloride infusion in type 1 (insulin-dependent) diabetes mellitus.

Authors:  P Stenvinkel; A K Saggar-Malik; H Wahrenberg; U Diczfalusy; J Bolinder; A Alvestrand
Journal:  Diabetologia       Date:  1991-02       Impact factor: 10.122

5.  Cell inward transport of L-DOPA and 3-O-methyl-L-DOPA in rat renal tubules.

Authors:  P Soares-da-Silva; M H Fernandes; P C Pinto-do-O
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

6.  Validity of urinary monoamine assay sales under the "spot baseline urinary neurotransmitter testing marketing model".

Authors:  Marty Hinz; Alvin Stein; Thomas Uncini
Journal:  Int J Nephrol Renovasc Dis       Date:  2011-07-20

7.  Roles of dopamine receptor on chemosensory and mechanosensory primary cilia in renal epithelial cells.

Authors:  Viralkumar S Upadhyay; Brian S Muntean; Sarmed H Kathem; Jangyoun J Hwang; Wissam A Aboualaiwi; Surya M Nauli
Journal:  Front Physiol       Date:  2014-02-26       Impact factor: 4.566

8.  Management of L-dopa overdose in the competitive inhibition state.

Authors:  Marty Hinz; Alvin Stein; Ted Cole
Journal:  Drug Healthc Patient Saf       Date:  2014-07-22

Review 9.  Personalized Management of Pheochromocytoma and Paraganglioma.

Authors:  Svenja Nölting; Nicole Bechmann; David Taieb; Felix Beuschlein; Martin Fassnacht; Matthias Kroiss; Graeme Eisenhofer; Ashley Grossman; Karel Pacak
Journal:  Endocr Rev       Date:  2022-03-09       Impact factor: 19.871

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.